News

A new study suggests that, after having a specialized AI tool taken away, clinicians were less proficient at colonoscopies.
Last November, in the days following Donald Trump’s election, leaders at the National Institutes of Health began discussing ...
A draft of RFK Jr.'s much-awaited strategy for a healthier America softens rhetoric on agricultural chemicals and stresses ...
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.
With U.S. funding for science at risk, a longtime advocate sees ‘light at the end of the tunnel’ in Washington.
Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...
In RFK Jr.’s America, it will never be safe to practice public health or medicine," write an epidemiologist and a former CDC ...
Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients ...
In at least six internal calls on Monday, CDC employees told leaders they worried that the agency wasn’t prepared for future ...
Keeping blood pressure below 120/80 lowers risk of dementia, as well as heart and kidney disease, new guidelines say.
The inclusion of pregnant participants in RCTs has remained flat over the past 15 years. Changing this norm will require ...
When U.S. regulators aren’t in the room while global standards are written, the future of patient safety, medical innovation, ...